Comparative clinical effect of Varunadhya Taila Uttar Basti and Matra Basti along With Kanchanara Guggulu orally in the management of Mootraghata wsr benign prostatic hyperplasia - an open labelled randomized clinical study.
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Relief in the clinical symptoms of Mootraghata (Benign Prostatic Hyperplasia).
研究概览
简要总结
In mutravaha strotas vikaras, the line of treatment is basti chikitsa. So to check which kind of basti chikitsa shows better result, I took this condition as an opportunity. After completing this study, the results will be helpful in future to make standard treatment protocol for BPH.
In this study, I will give uttarbasti and matrabasti in to two different groups and also give kanchanara guggulu with luke warm water. The expected outcome of this study is to get symptomatic relief from the BPH. After completion of the study the conclusion will be made.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 40.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- Male
入选标准
- •1.The patients having three or more signs from the diagnostic criteria (Benign Prostatic Hyperplasia).
- •blood pressure between 80 and 60 mmHg to 140 and 90 mmHg;
- •RBS below 140 mg/dl
- •As per the USG study, retention of urine with residual urine less than 200 ml.
- •Prostate size less than 200 cc.
- •Uttarbasti-arha.
排除标准
- •Patients less than 40 years and more than 70 years
- •Patients with malignancy, congenital deformities of the urogenital tract, or any abdominal-pelvic pathology other than BPH
- •Systemic diseases like chronic renal failure CRF, uncontrolled hypertension BP is more than 150 by 90 of mmHg, diabetes mellitus RBS greater than 150 mg by dl,
- •Patients with hematuria and urolithiasis have localized infections.
- •Patients with chief complaints of tuberculosis, paralysis, or Parkinsonism will be excluded.
- •Known cases of cardiac diseases History Of MI, IHD.
- •Patient is HIV, HBsAg, HCV, or VDRL positive.
- •Chronic retention of urine with residual urine of more than 200 ml
- •Prostate size more than 200 cc.
- •Complications such as hydroureter, hydronephrosis, stone formation, recurrent infection, bladder changes, Stricture urethra, Prostate carcinoma, idiopathic bladder neck obstruction, bladder neck hypertrophy, and haematuria 11.bastianarha.
结局指标
主要结局
Relief in the clinical symptoms of Mootraghata (Benign Prostatic Hyperplasia).
时间窗: 21 days
次要结局
- Decrease In Size Of Prostate(21 DAYS)
研究者
Keyur Rajeshbhai Chudasama
Shree Swaminarayan Ayurvedic Collage
